The US FDA = Food and Drug Administration has announced that it has recommended that pharmaceutical companies that manufacture new coronavirus vaccines develop vaccines for the Omicron strain of the mutant virus for booster doses from this fall onwards.

On the 30th of last month, the FDA recommended that pharmaceutical companies develop a new coronavirus vaccine that will be used for booster vaccinations after this fall, adding ingredients corresponding to the Omicron strain of the mutant virus to the current vaccine composition. Was announced.



The new vaccine should be developed based on "BA.4" and "BA.5", which are currently increasing in the proportion of infected people among the Omicron strains.



As of the 28th of last month, it is estimated that more than 50% of infected people in the United States are "BA.4" and "BA.5".



An external expert committee meeting on the 28th of last month recommended the use of vaccines for the Omicron strain in preparation for the spread of the infection, which has been a concern since the fall.



"It's very important to have a safe and effective vaccine that can prevent the severe symptoms of the mutant virus," the FDA said.